e-therapeutics plc
MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY

Abstract:

There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD). ##STR00001##